Tuesday, July 16, 2019 2:22:31 PM
I'll just do a quick recalculation below as there have been some shares added to the float since my last post back in February (HERE). This post assumed no holders of shares from the last financing sold. We definitely know at least one entity from the last offering liquidated their entire position and there are a few others listed on the S3 who I never saw 13Fs for. This means they either sold immediately or they don't manage at least $100M in assets. In any event after the above calculation form my last post on this topic I came up with a float of ~6.5M - 7M shares. Since that time Armistice Capital liquidated their entire 1.5 M share position so that would bring the previously calculated float up to ~8M - 8.5M shares.
For the following calculation I am going to make less assumptions than I did in the post above and only use numbers that I can verify. The main assumptions I am going to use are that Eastern Capital is still holding all their shares and the original Marker shareholders with the largest positions (John Wilson, Ann Leen, Juan Vera, BCM, Malcolm Brenner, Cliona Rooney, & Helen Heslop) are not going to sell anytime soon.
Current outstanding shares as of March 31, 2019: 45,484,483 (10Q)
If we subtract all the shares reported on 13Fs (15,282,725) found on fintel.io (HERE) we get 30,201,758.
Now let's subtract the 10,046,901 shares that John Wilson (13D, Ann Leen (13D), & Juan Vera (13D) own. This brings us to 20,154,857.
Per the S3 from last year (HERE) BCM, Salt Free LP (Malcolm Brenner & Cliona Rooney), and Helen Heslop own a combined 3,489,080 shares. If we subtract those we get 16,665,777.
Eastern Capital as of the last 13D (HERE) owns 3,633,334 shares. Subtract these and that brings the float down to 13,032,443.
So I would put the actual float somewhere between my first calculation from February (adding back the shares we know Armistice sold) and the calculation in this post. ~8M - 13M shares.
For the following calculation I am going to make less assumptions than I did in the post above and only use numbers that I can verify. The main assumptions I am going to use are that Eastern Capital is still holding all their shares and the original Marker shareholders with the largest positions (John Wilson, Ann Leen, Juan Vera, BCM, Malcolm Brenner, Cliona Rooney, & Helen Heslop) are not going to sell anytime soon.
Current outstanding shares as of March 31, 2019: 45,484,483 (10Q)
If we subtract all the shares reported on 13Fs (15,282,725) found on fintel.io (HERE) we get 30,201,758.
Now let's subtract the 10,046,901 shares that John Wilson (13D, Ann Leen (13D), & Juan Vera (13D) own. This brings us to 20,154,857.
Per the S3 from last year (HERE) BCM, Salt Free LP (Malcolm Brenner & Cliona Rooney), and Helen Heslop own a combined 3,489,080 shares. If we subtract those we get 16,665,777.
Eastern Capital as of the last 13D (HERE) owns 3,633,334 shares. Subtract these and that brings the float down to 13,032,443.
So I would put the actual float somewhere between my first calculation from February (adding back the shares we know Armistice sold) and the calculation in this post. ~8M - 13M shares.
Friends don't let friends place market orders
Recent MRKR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:08:49 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/20/2026 08:07:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/20/2026 08:05:49 PM
- Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results • GlobeNewswire Inc. • 03/18/2026 09:31:30 PM
- Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:06:45 PM
- Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:10:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:15 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/17/2025 09:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:20:47 PM
- Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:29:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:36:59 PM
- Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:03:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:54:39 PM
- Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:15:00 PM
- Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program • GlobeNewswire Inc. • 10/06/2025 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 11:30:37 AM
- Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 08/28/2025 12:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 11:16:20 AM
